Cargando…
Neuropeptide Y: a potential theranostic biomarker for diabetic peripheral neuropathy in patients with type-2 diabetes
BACKGROUND: Diabetic peripheral neuropathy (DPN), the most common microvascular complication of type-2 diabetes mellitus (T2DM), results in nontraumatic lower-limb amputations. When DPN is not detected early, disease progression is irreversible. Thus, biomarkers for diagnosing DPN are needed. METHOD...
Autores principales: | Cho, Noo Ree, Yu, Yeuni, Oh, Chang-Kyu, Ko, Dai Sik, Myung, Kyungjae, Lee, Yoonsung, Na, Hee Sam, Kim, Yun Hak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438932/ https://www.ncbi.nlm.nih.gov/pubmed/34729143 http://dx.doi.org/10.1177/20406223211041936 |
Ejemplares similares
-
Diabetic Peripheral Neuropathy as a Risk Factor for Sarcopenia
por: Oh, Tae Jung, et al.
Publicado: (2019) -
SUDOSCAN in Combination with the Michigan Neuropathy Screening Instrument Is an Effective Tool for Screening Diabetic Peripheral Neuropathy
por: Oh, Tae Jung, et al.
Publicado: (2022) -
Pharmacological and Nonpharmacological Treatments for Painful Diabetic Peripheral Neuropathy
por: Jang, Han Na, et al.
Publicado: (2023) -
Liver fibrosis indices are related to diabetic peripheral neuropathy in individuals with type 2 diabetes
por: Kim, Kyuho, et al.
Publicado: (2021) -
Reliability and Quality of YouTube Videos on Ultrasound-Guided Brachial Plexus Block: A Programmatical Review
por: Cho, Noo Ree, et al.
Publicado: (2021)